Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zydena for ED after nerve-sparing radical prostatectomy
NCT03142542Phase 4Unknown
- Sponsor
- Samsung Medical Center
- Start
- May 2017
- Primary completion
- May 2019
01
Overview
Phase 4, randomised, double-blind trial in erectile dysfunction (ED) comparing Zydena 75mg with Placebo (2 arms). Primary endpoint: International Index of Erectile Function - Erectile Function domain at 32 weeks. Status: unknown.
02
Drugs
udenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03142542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142542.